Creatine Steps Out of the Gym: Animal Study Points to a New Adjunctive Clue for Cancer Immunotherapy
A preclinical study brings a common sports supplement into a central question in tumor immunology: if dendritic cells can be supplied with enough energy, can killer T cells more powerfully recognize and attack cancer cells? The answer remains before human trials.